Journal: Cell Death & Disease
Article Title: UHRF1-mediated HIF-1α stabilization promotes ovarian cancer through metabolic reprogramming and angiogenesis
doi: 10.1038/s41419-025-08033-w
Figure Lengend Snippet: A , B Periodic acid-Schiff (PAS) (pink) and CD31 (brown) double staining of tumor tissues from xenograft mice. PAS+/CD31+ tubular structures represent conventional blood vessels lined with CD31-positive endothelial cells. Adjacent PAS+/CD31− tubular structures suggest vasculogenic mimicry (VM). C , D WB analysis of VEGF expression levels in cells treated with CoCl₂ for 24 h. E Representative images of the tube formation assay in SKOV3 stable cell lines. F Representative images of the tube formation assay in HUVEC cells after 72 h of culture with conditioned medium from the stable SKOV3 cell line. G Images of the Transwell migration assay and tube formation assay in HUVEC cells after 72 hours of culture with conditioned medium from the stable SKOV3 cell line. H , I Images of the Transwell migration assay and tube formation assay in HUVEC cells after 72 h of culture with conditioned medium from the stable SKOV3 cell line, followed by treatment with the HIF-1α inhibitor PX-478. J , K IC50 analysis of Bevacizumab in UHRF1-knockdown A2780 cell lines. ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Article Snippet: The human OC cell line SKOV3 (CL-0215) was purchased from Wuhan Procell Life Science & Technology Co., Ltd., and A2780 (STCC10706P-1) was purchased from Wuhan Servicebio Technology Co., Ltd.
Techniques: Double Staining, Expressing, Tube Formation Assay, Stable Transfection, Transwell Migration Assay, Knockdown